Skip to main content

Cytarabine News

FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia

August 3, 2017 – The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML)...

FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter

including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...

FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials

Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall...

FDA Medwatch Alert: Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility

ISSUE: Bedford Laboratories announced a nationwide recall of three lots of cytarabine for injection—2066986, 2111675, and 2131148—because vials have a potential risk of a lack of sterility. The risk w...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Leukemia, Non-Hodgkin's Lymphoma

Cytarabine patient information at Drugs.com